GlassScriptPhysician profile
Kenneth Evan Nekl
NPI 1336239029
$1,390.33
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,023 · 2020: $337 · 2022: $30.37.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $325.94 | 2019-2020 | |
| Amgen INC. | $167.24 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $167.01 | 2019-2020 | |
| Insulet Corporation | $109.65 | 2019 | |
| Pfizer INC. | $91.92 | 2019 | |
| Abbott Laboratories | $70.01 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $61.53 | 2019-2022 | |
| Amarin Pharma, INC. | $57.17 | 2019-2020 | |
| Radius Health, INC. | $54.02 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.68 | 2019-2020 | |
| Lilly USA, LLC | $50.86 | 2019-2020 | |
| Abbvie INC. | $48.30 | 2019-2020 | |
| Valeritas, INC. | $27.39 | 2019 | |
| Mannkind Corporation | $21.90 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.38 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $16.49 | 2019 | |
| Antares Pharma, INC. | $13.70 | 2019 | |
| Ibsa Pharma INC. | $13.32 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.86 | 2019 | |
| Endo Pharmaceuticals INC. | $11.96 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Nekl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.